Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06035068

SLN Mapping and ICG Dye for Vulvar Cancer

Sentinel Lymph Node Mapping and Detection With Indocyanine Green and Spy-Phi Handheld Camera Technology in Early-Stage Vulvar Cancer (PILOT)

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
Tufts Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Doctors typically use blue dye to assist in locating and extracting lymph nodes for biopsy. However, this process can prove somewhat challenging for both patients and medical teams due to its need for extensive coordination and the assistance of a nuclear medicine team. Some studies have talked about using a different method to find these lymph nodes using a special dye called Indocyanine Green (ICG). This method involves shining a special camera on the skin. So far, no studies have directly compared the ICG method to the standard blue dye. The ICG camera could make things easier for patients and doctors, and more patients might choose to have their lymph nodes checked with this new method. The goal of our study is to see if using the ICG dye is just as good as the standard method of blue dye.

Conditions

Interventions

TypeNameDescription
DRUGIndocyanine greenIndocyanine green (ICG) is a fluorescent dye that has been used for the imaging of cancers in the body for more than 30 years.

Timeline

Start date
2025-11-01
Primary completion
2025-12-01
Completion
2026-01-01
First posted
2023-09-13
Last updated
2025-09-29

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06035068. Inclusion in this directory is not an endorsement.

SLN Mapping and ICG Dye for Vulvar Cancer (NCT06035068) · Clinical Trials Directory